Recent Update on Chlamydia and Cancer
As of the 11th of September 2023
New research findings suggest that the common sexually transmitted infection, Chlamydia, might play a role in the development of certain types of cancer. Studies have identified a potential connection between the prolonged presence of Chlamydia infections and an increased risk of developing cervical and ovarian cancers. While the exact mechanisms remain under investigation, it’s believed that the chronic inflammation caused by the bacteria could lead to DNA damage, which in turn can initiate the onset of cancerous growths. Health professionals are emphasizing the importance of regular STI screenings and timely treatment to not only prevent the spread of Chlamydia but also reduce the potential long-term health risks associated with untreated infections.
Chlamydia may pave way for cancer
As of the 24th of June 2013
Scientists in Germany have reported that persistent infection with chlamydia may cause cancer by causing mutations in the host DNA and by inhibiting attempts by the host to repair the damage.
Chlamydia is the most common STI, infecting over 90 million people across the globe every year. It is often asymptomatic, can persist for many years unnoticed, and is a leading cause of infertility. It is also increasingly becoming harder to treat due to antibiotic resistance, further contributing to persistent infection.
There is growing evidence that chlamydia can cause changes to host cell DNA, which in turn is implicated in developing a range of cancers, such as cervical and ovarian cancer.
Not only does the evidence point to chlamydia changing host cell DNA, but it also seems to inhibit the repair mechanisms that would usually kick in to cause the so cells to die. This means that the damaged DNA was passed on, causing more abnormal cells, which is a hallmark of cancer
It is important to realise that this is only one study, and more research is needed before we make too many assumptions, but it is definitely food for thought!